Insulin and Kidney Function Study


Study Information
Purpose of Study
The purpose of this study is to determine how insulin levels in the blood affect the way the kidneys eliminate phosphate into the urine in people with type 2 diabetes that have either normal or moderately reduced kidney function.
Associated Lab
Queen’s-KRU (Kidney Research Unit)
Location
Kingston Health Sciences Centre – Kingston General Hospital site. 76 Stuart St.
Investigators
Co-Principal Investigators: Drs. Rachel Holden and Christine White, Queen’s University/Kingston Health Science Centre – Kingston General Hospital site Co-investigators: Aysha Draves, M.Sc. (Candidate), Queen’s University, Dr. Robyn Houlden and Dr. Jocelyn Garland, Queen’s University/Kingston Health Sciences Centre – Kingston General Hospital site, and Dr. Michael A. Adams, Biomedical and Molecular Sciences, Queen’s University Who is the main contact? Name: Corinne Babiolakis
Benefits of Participating
You will not benefit directly from this study; however results from this study may improve the understanding of how insulin affects phosphate excretion and may benefit people in the future.
Compensation
Compensation is $50 for 1 visit.

Inclusions:
  • Adults aged 40 and 80 who have non-insulin dependent type 2 diabetes with or without reduced kidney function

Exclusions:
  • Known allergy to contrast
  • Known allergy to shellfish
  • Insulin use

What You'll Be Asked to Do:
If you decide to take part in this study, you will be asked to visit the hospital for one visit. The test will take approximately 5 hours to complete. The visit includes: Blood samples, Urine samples, Consumption of an oral phosphate drink (1 cup of water that contains a total of 500 mg of phosphate), Questions regarding your medication and supplement use.

Login or Sign Up to Get Started